Role of magnetic resonance venography in assessment of intra-thoracic central veins in hemodialysis patients  by Abdel Latif, Mahmoud et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2015) 46, 899–906Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comORIGINAL ARTICLERole of magnetic resonance venography
in assessment of intra-thoracic central veins
in hemodialysis patients* Corresponding author.
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2015.06.006
0378-603X  2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Mahmoud Abdel Latif *, Hossam El Wakeel, Dina Gamal, Ahmed G. SadekMansoura University Hospital (MUH), EgyptReceived 20 March 2015; accepted 12 June 2015
Available online 20 August 2015KEYWORDS
MRV;
Hemodialysis patients;
DSV;
Intrathoracic central veinsAbstract Aim: To determine diagnostic accuracy of magnetic resonance venography (MRV) in
assessment of the patency and steno-occlusive disease of intrathoracic central veins in hemodialysis
patients.
Patients and methods: Between February 2013 and December 2014, 40 hemodialysis patients with
suspected intrathoracic central venous stenosis were examined by MRV (phase contrast in 35
patients and contrast enhanced in 5 uncooperative patients). Digital subtraction venography
(DSV) was done in the 40 patients and used as the standard reference. The results of MRV were
compared with those of DSV. Kappa index with percent agreement between 2 methods was calcu-
lated.
Results: The results showed excellent agreement as MRV detected 140 out of 141 patent, and all 36
stenotic and 62 out of 64 occluded segments of intra-thoracic central veins with k were 1.00, 1.00 and
0.97 and P value =<0.001, 0.001 and 0.023 respectively. MRV had 98.6% sensitivity, 100% speci-
ﬁcity and 99.3% accuracy in diagnosis of patency and stenoocclusive disease of central veins.
Conclusion: MRV is a highly sensitive technique in the diagnosis of patency and steno-occlusive dis-
ease of intrathoracic central veins and may be used as an alternative to DSV for the abnormalities of
central veins in hemodialysis patients.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A common and signiﬁcant problem in the management of
hemodialysis patients is central venous steno-occlusive disease
(CVSD), the incidence of which has been reported in theliterature to be in the range of 25–40% (1). This can result
in the loss of the access site, increased venous pressure on
the dialysis machine leading to its stoppage, and arm swelling
due to venous hypertension. Prompt treatment should be
required (2).
The cause of central vein stenosis used to be iatrogenic; due
to repeated insertion of dialysis catheters in the same vein over
long period; and also the repeated infection that occurs at the
tip of the catheter (3).
Fig. 1 Phase contrast MRV of a female patient aged 35 years
(control group). 3D reformate of phase contrast MRV showed
patent central veins.
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both clinical and imaging ﬁndings. Digital subtraction contrast
venography is the current reference standard (4).
Ultrasonography has been widely used for the detection of
CVSD, but it can only diagnose stenosis in internal jugular
vein and subclavian vein and cannot detect stenotic lesions
in other central veins such as brachiocephalic veins and supe-
rior vena cava (SVC) (5).
Magnetic resonance venography (MRV) shows to be more
accurate and reliable than ultrasonography in diagnosis of
CVSD, as the images obtained from MRV show better mor-
phological ﬁndings detecting the length and degree of the
lesions (4), which indicate whether interventional procedures
are necessary and can identify the length of the lesion that
requires crossing with the catheter and guide wire (2).
MRV can be done by contrast and noncontrast techniques.
Noncontrast MRV using Time of Flight (TOF) and phase con-
trast (PC) techniques allows noninvasive visualization of the
venous structures (6). Contrast enhanced MRV can also be
done safely with using small dose of contrast such as gadoter-
ate meglumine (Dotarem; Guerbet; Villepinte, France) instead
of gadopentetate dimeglumine (Magnevist, Schering, Berlin,
Germany). This contrast proved to be more safe in patients
with renal impairment and less likely to induce nephrogenic
systemic ﬁbrosis (NSF) (7,8).
2. Aim of the work
To determine the diagnostic accuracy of phase contrast and
three-dimensional gadolinium-enhanced magnetic resonance
venography (3D-Gd-MRV) in assessment of patency and
steno-occlusive disease of intrathoracic central veins in
hemodialysis patients.
3. Patients and methods
3.1. Patients
During the period from February 2013 to December 2014, this
study was conducted in the Radiology Department of
Mansoura University Hospitals (MRI unit and Emergency
Hospital). At ﬁrst 45 patients were enrolled but ﬁve of them
were excluded due to contraindications to examination; three
Patients were with metallic prosthesis, one cardiac patient with
pacemaker and one patient had claustrophobia. So, ﬁnally, 40
patients were included, and their age ranged from 25 to 70 years
with mean age of 47.5 years. Inclusion criterion was hemodial-
ysis patients with suspected intrathoracic central venous steno-
sis referred to us from the vascular surgery department. All
patients had a history of previous catheterization in the internal
jugular and/or the subclavian veins. 15 patients had manifesta-
tions of venous hypertension (all presented with arm swelling
and 4 of them had associated facial swelling).
All participated patients signed the informed consents
required by the Human Study Committee (see Figs. 1–5).
3.2. Methods
Phase contrast MRV was done in 35 patients and gadolinium-
enhanced in 5 uncooperative patients for diagnosis of patency
and stenoocclusive disease of intrathoracic central veins inhemodialysis patients.Digital subtraction venographywas done
in all the 40 patients and used as the gold standard reference.
MRI examination performed on a 1.5-T unit (Ingenia;
Philips Medical Systems, Best, the Netherlands) using a torso
phased-array coil centered over the thoracic inlet. The ﬁeld
of view (FOV) covered the region from above the clavicle to
the diaphragm in craniocaudal extension and the whole chest
in axial diameter.
3.2.1. Acquisitions of MRV
MRV was done by phase contrast (PC) technique in 35
patients. Phase contrast technique is a gradient echo technique
with TR 8.0 ms; TE 4.5 ms; ﬂip angle 15; FOV 300 mm; Venc
20 cm/s; total scan time 6 min and 36 s. The remaining 5
patients of the diseased group were critically ill and cannot
withstand the long time examination of phase contrast tech-
nique, so, MRV examinations were conducted using the con-
trast enhanced (CE) technique, as, gadolinium-based contrast
material (Dotarem; Guerbet; Villepinte, France) was adminis-
tered as a bolus injection at a weight adjusted dose
(0.2 mmol/kg). 3D Dotarem enhanced MRV was performed
during end-inspiratory breath-holding in the arterial phase
and then in the venous phase of the central chest veins. A ﬁxed
delay of 20 s between both acquisitions was set, allowing the
patient to breath in between. All injections were administered
with ﬂow rate of 2 mL/s and a 20 mL of normal saline solution
was ﬂushed through a 22-gauge injection cannula placed in
peripheral vein. 3D data sets were acquired in the coronal
plane using a spoiled GRE sequence with TR 4.6 ms; TE
1.8 ms; ﬂip angle 30; FOV (maximum, 500 mm); matrix
200–512; 1 excitation; bandwidth 390 Hz/pixel; and time of
acquisition 23 s. Immediately after examination, a hemodialy-
sis session was arranged to each case, observed for 24 h for
Fig. 2 (a–c) Source image of phase contrast MRV. Findings: patent left subclavian, brachiocephalic and internal jugular veins (a).
Occluded segment at the end of right subclavian vein (white arrow) (b). Patent SVC (c). 3D reformatted phase contrast MRV shows
segment of total occlusion at proximal end of RT subclavian vein with severe stenosis of RT brachiocephalic vein (white arrows) (d).
(e and f) DSV images. Findings: total occlusion at the end of right subclavian (thick arrow). Attenuated right brachiocephalic vein.
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Fig. 3 Phase contrast MRV of male patient aged 75 years, with history of bilateral dialysis catheter insertion and failed access on right
side seeking for dialysis access. (A–D) Source images of phase contrast MRV. (E and F) 3D reformate phase contrast MRV. Findings:
Occluded right subclavian and right brachiocephalic veins (white circles) (A and B). Patent left subclavian vein (Lt SV) (A–C and F).
Patent left brachiocephalic vein (LtBC) (D and E). And patent superior vena cava (SVC) (C). Aortic arch (A) (C and D). (a–c) DSV
images. Findings: patent left subclavian vein, left brachiocephalic vein and SVC (a and b). Occluded right subclavian vein (c).
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Fig. 4 (a) Dotarem enhanced MRV and (b) DSV image on the right side. Findings: total occlusion at the right subclavian vein (white
arrow).
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patient clinic for three months for any delayed complication.
Reconstruction of images was done by maximum intensity
projections (MIPs) and multi-planar reformations (MPRs)
using the standard software of the magnetic resonance unit.
Resulted images describe examined veins whether they are
patent, stenotic or occluded.
3.2.2. Digital subtraction venography
Digital subtraction venography (DSV) was conducted on all
the 40 patients as the standard reference. An intravenous can-
nula was inserted at the veins of hand or forearm, 50 ml iodi-
nated contrast was injected manually as rapid as possible
(10 ml bolus at each run) and image acquisition was done
through the mobile C-arm (BV pulsera; Philips Medical system,
the Netherlands). There was difﬁcult cannulation in 5 patients,
so they were cannulated through the arteriovenous ﬁstula to be
examined on the affected side. The same procedure was
repeated at the other side. The aim was to assess the patency
of subclavian veins, brachiocephalic veins and superior vena
cava, interpreted as patent, stenotic or totally occluded.
Immediately after examination, a hemodialysis session was
arranged to each case, observed for 24 h for signs of anaphy-
laxis, and discharged on follow-up in the outpatient clinic
for three months for any delayed complications.
Interpretation of the results was done separately by 2 inde-
pendent radiologists (A Galal and M Abdel Latif), both had
experience of 15 and 10 years respectively in MRV and DSV.
They were blinded to the results of the other modality. Then
the ﬁndings of the both modalities were correlated together
as regards the ability to assess each vein. Interpretations of
MRV were compared to interpretations of DSV.
3.2.3. Statistical analysis
Statistical analysis was carried out via Statistical package for
social Science (SPSS) version 17 program on windows XP.
Qualitative data were represented in the form of number and
percentage. Kappa index with percent agreement between
methods was calculated. Results were considered statistically
signiﬁcant if p value is less than or equal to 0.05.4. Results
This study included 40 patients who were hemodialysis
patients with suspected intrathoracic central venous stenosis.
Phase contrast (PC) MRV technique was done in 35
patients. The remaining 5 patients were uncooperative and
examined by contrast enhanced MRV technique. All the 40
patients underwent DSV for comparison.
Comparison of the results of MRV and DSV showed that
there was excellent agreement for diagnosis of normal (patent)
and abnormal (stenosed or occluded) segments of all central
veins. For patent, stenosed and occluded right IJV, k= 0.93,
1.00 and 0.86 and P value = <0.001, 0.023 and <0.001
respectively. MRV diagnosed all stenosed and occluded seg-
ments in right SCV with k= 1.00 and P value = <0.001
for diagnosis of patent, stenosed and occluded right SCV.
For patent, stenosed and occluded right BCV, K = 1.00,
1.00 and 1.00 and P value = <0.001, 0.079 and <0.001
respectively. k was 1.00 and P value = <0.001 for diagnosis
of patent and occluded left IJV, left SCV and SVC. For patent,
stenosed and occluded left BCV, k= 1.00, 1.00 and 1.00 and P
value =<0.001, 0.023 and 0.002 respectively.
The overall results showed excellent agreement as MRV
detected 140 out of 141 patent, all 36 stenotic and 62 out of
64 occluded segments of intra-thoracic central veins with k
were 1.00, 1.00 and 0.97 and P value = <0.001, 0.001 and
0.023 respectively (Table 1).
MRV diagnosed abnormalities of the intra-thoracic central
veins with sensitivity = 98.6%, speciﬁcity = 100% and accu-
racy = 99.3% in diagnosis of patency and steno-occlusive dis-
ease of central veins (Table 2).
No signiﬁcant complication caused by contrast in contrast-
enhanced MRV studies.5. Discussion
Detection of central veins stenosis has been a challenging issue;
since the assessment of central veins of the chest is very difﬁ-
cult with sonography, MRV provides excellent assessment of
Fig. 5 Dotarem enhanced MRV. Findings: thrombosed right
brachiocephalic vein and attenuated right internal jugular vein with
patent right subclavian and superior vena cava. Patent left
subclavian, left brachiocephalic veins. (a and b) DSV image.
Findings: thrombosed right brachiocephalic vein with patent right
subclavian (a). Patent left subclavian, left brachiocephalic veins (b).
Table 1 Comparison of the overall results of both MRV and
DSV.
Category MRV DSV K 95%CI Percent
agreement
(%)
P value
Patent 140 141 1.00 0.87–1.00 100 <0.001
Stenosed 36 36 1.00 0.44–1.00 100 0.001
Occluded 62 64 0.97 0.92–1.00 98.4 0.023
Not
assessed
1 4
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(1).
Although CT venography is a reliable test it provides accu-
rate and quick method in assessing the veins. The use of con-
trast materials beside the radiation exposure hazards limited its
use in patients with renal impairment especially who are plan-
ning for access creation. While in MRV, the non-contrast tech-
nique renders its safe in renal impairment patients (9,10).
Digital subtraction venography remains the gold standard,
but its use is limited also due to its invasive nature and radia-
tion exposure risks (4).
All previous studies encouraged researchers to apply MRV
in hemodialysis patients. Oxtoby et al. (11) used the contrast
enhanced MRV to evaluate the patency of central veins on
17 patients using 1.0 Tesla MRI and injection of gadopentetate
dimeglumine (Magnevist, Schering, Berlin, Germany), at a
dose of 0.4 ml/kg body weight. The results showed that CE-
MRV is a reliable diagnostic tool for the evaluation of patency
of central veins. MRV successfully predicted an appropriate
site in 10 patients for creation AVF. In the remaining 7
patients, MRV was valuable in conﬁrming or excluding the
clinical suspicion of central venous thrombosis. Kroencke
et al. (4) published similar study on 16 patients clinically sus-
pected with thrombosis in axillary and central veins. The image
quality in MRV was good and the MRV did not miss any ﬁnd-
ings obtained by the gold standard DSV, color Doppler or CT
studies. Shankar et al. (12) used phase contrast MRV tech-
niques in 25 children underwent central venous catheter inser-
tion. MRV results were superior to color Doppler ultrasound
as regards accuracy, and to venography as regards less expo-
sure to radiation hazards. MRV showed thrombosis of intra
thoracic veins in 11 patients who had patent neck veins on
ultrasound. MRV identiﬁed a patent vein for reinsertion of
central venous catheter in 22 of 25 children. At operation,
venous patency was conﬁrmed in 20 patients (91% speciﬁcity).
In 2012, Gao et al. (1) used 3D contrast enhanced MRV
using dimeglumine gadopentetate in the examination of 14
hemodialysis patients to detect stenosis in their central veins.
The results were compared to those of DSV. MRV detected
stenosis in central veins in 13 patients. In the last patient the
results of MRV were inconclusive. Sensitivity of MRV reached
93%. No complication was reported from using contrast
agent.
The results of our study were in agreement with the previ-
ous studies as the sensitivity, speciﬁcity and accuracy of
MRV compared to DSV were 98.6%, 100% and 99.3% respec-
tively in the diagnosis of patency and steno-occlusive disease of
central veins.
Table 2 Sensitivity, speciﬁcity and accuracy of MRV in the detection of stenoocclusive disease of
central veins.
Sensitivity
(95%CI)
Speciﬁcity Accuracy PPV NPV
MRV 98.6%
(97–98.6%)
100%
(98.4–100%)
99.3%
(97.7–99.3%)
100%
(98.4–100%)
98.6%
(97–98.6%)
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from gadoterate meglumine (Dotarem) rather than other
gadolinium based agents such as gadopentetate dimeglumine
(magnevist); Gordon (13) said that there are no reported
cases of NSF after gadoterate meglumine (Dotarem) injec-
tion. So, in our study, 5 patients who were critically ill and
could not withstand the relatively long time examination of
phase contrast MRV, were studied using the contrast enhanced
MRV technique using the gadoterate meglumine (Dotarem)
as a contrast agent.
Noncontrast techniques such as phase contrast MRV pro-
vided another safe, noninvasive option in patients with renal
impairment because no contrast is needed. However, Elkins
and Alley (14) said that the difﬁculty we faced in phase con-
trast MRV was low image quality of the 3D reformats in par-
tially occluded segments. In our study, we met this problem in
three cases (case numbers 11, 15 and 16) who had stenotic seg-
ments in right SCV and right BCV, while the image quality in
patients with patent veins was conclusive. This may be due to
the stagnant ﬂow in the partially occluded veins. We solved
this problem by revising the 2D source images for occluded
veins.
Elkins and Alley (14) found another difﬁculty was the long
time of examination of phase contrast MRV that reached more
than 6 min and the patient should be immobile all this period.
This technique needs highly oriented, cooperative patients and
the procedure should be fully explained to them. In the current
study, we performed contrast enhanced technique which needs
shorter time (23 s) in 5 uncooperative patients.
In this study, the quality of the images of CE MRV was
higher than that of the phase contrast MRV. This is in agree-
ment with Layer et al. (15) who conﬁrmed that contrast-
enhanced MRV has the advantage of high image quality as
compared with phase contrast, as it has high signal to noise
ratio. Also it has the advantage of increasing vascular signal
and reducing background signal without risk of saturating
slowly ﬂowing blood. Contrast-enhanced vessels appear bright
regardless of the presence of slow ﬂow as the vascular signal
can be further increased by using a small amount of contrast
agent (Dotarem). Also it has the advantage of short examina-
tion time than phase contrast technique, so motion artifact is
less with CE MRV than phase contrast technique. The disad-
vantage of CE MRV is that the data must be collected quickly
while the contrast agent is still predominantly intra-venous.
Also repeated acquisitions are not always possible because
the contrast agent is rapidly distributed into the extra-
vascular spaces, beside the high cost of the contrast.
The main difﬁculty we faced while performing DSV was
dilution of the dye inside the veins as was reported by
Kroencke et al. (4) who also concluded that MRV showed
superiority in the assessment of internal jugular vein over the
gold standard DSV; it was difﬁcult in DSV to cannulate thisvein especially when it was occluded. This is in agreement with
our results, as MRV detected 14 cases with occlusion in inter-
nal jugular vein, while DSV detected only 12 cases.
Lastly, there was no reported hypersensitivity in all patients
who underwent contrast enhanced MRV.
6. Conclusion
MR venography is a valuable technique for assessing intratho-
racic central veins in regions inaccessible or poorly accessible
to sonography. The noninvasive nature of MRV should make
it preferable than DSV in the diagnosis of steno-occlusive dis-
ease of intrathoracic central veins in hemodialysis patients.
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